According to Gentian Diagnostics ASA's latest financial reports the company's current EPS (TTM) is $0.08714. In 2023 the company made an earnings per share (EPS) of -$0.11 an increase over its 2022 EPS that were of -$0.25.
Year | EPS | Change |
---|---|---|
2024 (TTM) | $0.08276 | -176.73% |
2023 | -$0.11 | -56.65% |
2022 | -$0.25 | -14.37% |
2021 | -$0.29 | 38.09% |
2020 | -$0.21 | -54.91% |
2019 | -$0.47 | 98.3% |
2018 | -$0.24 | 12.15% |
2017 | -$0.21 | 42.29% |
2016 | -$0.15 | 181.87% |
2015 | -$0.05233 | -6.45% |
2014 | -$0.05593 | -372.37% |
2013 | $0.02054 |